Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
1.290
-0.080 (-5.84%)
Aug 1, 2025, 4:00 PM - Market closed
Chimerix Market Cap
Citius Pharmaceuticals has a market cap or net worth of $14.42 million as of August 1, 2025. Its market cap has decreased by -90.62% in one year.
Market Cap
14.42M
Enterprise Value
15.32M
1-Year Change
-90.62%
Ranking
Category
Stock Price
$1.29
Market Cap Chart
Since July 6, 2017, Citius Pharmaceuticals's market cap has decreased from $30.70M to $14.42M, a decrease of -53.05%. That is a compound annual growth rate of -8.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 14.10M | -54.37% |
| Dec 31, 2024 | 30.90M | -74.31% |
| Dec 29, 2023 | 120.30M | 4.16% |
| Dec 30, 2022 | 115.50M | -48.64% |
| Dec 31, 2021 | 224.90M | 296.65% |
| Dec 31, 2020 | 56.70M | 92.20% |
| Dec 31, 2019 | 29.50M | 59.46% |
| Dec 31, 2018 | 18.50M | -42.19% |
| Dec 29, 2017 | 32.00M | 4.23% |
| Jul 6, 2017 | 30.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.35B |
| Johnson & Johnson | 402.82B |
| AbbVie | 334.40B |
| UnitedHealth Group | 241.34B |
| AstraZeneca | 236.88B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 223.66B |
| Novo Nordisk | 221.96B |